RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Prevalence of Complement-Mediated Cell Lysis-like Gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis Isolates From Japan (2014–2016)

      한글로보기

      https://www.riss.kr/link?id=A103363884

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background: Streptococcus dysgalactiae subsp. equisimilis (SDSE; a β-hemolytic streptococcus of human or animal origin) infections are emerging worldwide. We evaluated the clonal distribution of complement-mediated cell lysis-like gene (sicG) among S...

      Background: Streptococcus dysgalactiae subsp. equisimilis (SDSE; a β-hemolytic streptococcus of human or animal origin) infections are emerging worldwide. We evaluated the clonal distribution of complement-mediated cell lysis-like gene (sicG) among SDSE isolates from three central prefectures of Japan.
      Methods: Group G/C β-hemolytic streptococci were collected from three institutions from April 2014 to March 2016. Fifty-five strains (52 from humans and three from animals) were identified as SDSE on the basis of 16S rRNA sequencing data.; they were obtained from 25 sterile (blood, joint fluid, and cerebrospinal fluid) and 30 non-sterile (skin-, respiratory tract-, and genitourinary tract-origin) samples. emm genotyping, multilocus sequence typing, sicG amplification/sequencing, and random amplified polymorphic DNA (RAPD) analysis of sicG-positive strains were performed.
      Results: sicG was detected in 30.9% of the isolates (16 human and one canine) and the genes from the 16 human samples (blood, 10; open pus, 3; sputum, 2; throat swab, 1) and one canine sample (open pus) showed the same sequence pattern. All sicG-harboring isolates belonged to clonal complex (CC) 17, and the most prevalent emm type was stG6792 (82.4%). There was a significant association between sicG presence and the development of skin/soft tissue infections. CC17 isolates with sicG could be divided into three subtypes by RAPD analysis.
      Conclusions: CC17 SDSE harboring sicG might have spread into three closely-related prefectures in central Japan during 2014–2016. Clonal analysis of isolates from other areas might be needed to monitor potentially virulent strains in humans and animals.

      더보기

      참고문헌 (Reference)

      1 Davies MR, "Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases" 44 : 1442-1454, 2007

      2 Schrieber L, "Transmission of Streptococcus dysgalactiae subsp. equisimilis between child and dog in an Aboriginal Australian community" 61 : 145-148, 2014

      3 Vandamme P, "Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov" 46 : 774-781, 1996

      4 Vandamme, "Streptococcus dysgalactiae subsp. equisimilis"

      5 Fernie-King BA, "Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes" 103 : 390-398, 2001

      6 Oppegaard O, "Sequence diversity of sicG among group C and G Streptococcus dysgalactiae subspecies equisimilis isolates associated with human infections in western Norway" 33 : 273-277, 2014

      7 Åkesson P, "Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function" 271 : 1081-1088, 1996

      8 Minami M, "Prevalence of a streptococcal inhibitor of a complement-mediated cell lysis-like gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis" 62 : 884-887, 2011

      9 Broyles LN, "Population-based study of invasive disease due to β-hemolytic streptococci of groups other than A and B" 48 : 706-712, 2009

      10 McMillan DJ, "Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination" 5 : e11741-, 2010

      1 Davies MR, "Virulence profiling of Streptococcus dysgalactiae subspecies equisimilis isolated from infected humans reveals 2 distinct genetic lineages that do not segregate with their phenotypes or propensity to cause diseases" 44 : 1442-1454, 2007

      2 Schrieber L, "Transmission of Streptococcus dysgalactiae subsp. equisimilis between child and dog in an Aboriginal Australian community" 61 : 145-148, 2014

      3 Vandamme P, "Taxonomic study of lancefield streptococcal groups C, G, and L (Streptococcus dysgalactiae) and proposal of S. dysgalactiae subsp. equisimilis subsp. nov" 46 : 774-781, 1996

      4 Vandamme, "Streptococcus dysgalactiae subsp. equisimilis"

      5 Fernie-King BA, "Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes" 103 : 390-398, 2001

      6 Oppegaard O, "Sequence diversity of sicG among group C and G Streptococcus dysgalactiae subspecies equisimilis isolates associated with human infections in western Norway" 33 : 273-277, 2014

      7 Åkesson P, "Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function" 271 : 1081-1088, 1996

      8 Minami M, "Prevalence of a streptococcal inhibitor of a complement-mediated cell lysis-like gene (sicG) in Streptococcus dysgalactiae subsp. equisimilis" 62 : 884-887, 2011

      9 Broyles LN, "Population-based study of invasive disease due to β-hemolytic streptococci of groups other than A and B" 48 : 706-712, 2009

      10 McMillan DJ, "Population genetics of Streptococcus dysgalactiae subspecies equisimilis reveals widely dispersed clones and extensive recombination" 5 : e11741-, 2010

      11 Clinical and Laboratory Standards Institute, "Performance standards for antimicrobial susceptibility testing. Twenty-second Informational supplement, M100-S22"

      12 Centers for Disease Control and Prevention, "One Health"

      13 Yamaoka S, "Neonatal streptococcal toxic shock syndrome caused by Streptococcus dysgalactiae subsp. equisimilis" 29 : 979-981, 2010

      14 Malhotra-Kumar S, "Multiplex PCR for simultaneous detection of macrolide and tetracycline resistance determinants in streptococci" 49 : 4798-4800, 2005

      15 Takahashi T, "Invasive infection caused by Streptococcus dysgalactiae subsp. equisimilis: characteristics of strains and clinical features" 17 : 1-10, 2011

      16 Cohen-Poradosu R, "Group G streptococcal bacteremia in Jerusalem" 10 : 1455-1460, 2004

      17 Fujita T, "Genetic diversity in Streptococcus dysgalactiae subsp. equisimilis isolates from patients with invasive and noninvasive infections in a Japanese university hospital (2014-2015)" 70 : 100-104, 2017

      18 Smyth D, "DrsG from Streptococcus dysgalactiae subsp. equisimilis inhibits the antimicrobial peptide LL-37" 82 : 2337-2344, 2014

      19 Haenni M, "Diversity and mobility of integrative and conjugative elements in bovine isolates of Streptococcus agalactiae, S. dysgalactiae subsp. dysgalactiae, and S. uberis" 76 : 7957-7965, 2010

      20 Lo HH, "Distribution of virulence factors and association with emm polymorphism or isolation site among beta-hemolytic group G Streptococcus dysgalactiae subspecies equisimilis" 123 : 45-52, 2015

      21 Bramhachari PV, "Disease burden due to Streptococcus dysgalactiae subsp. equisimilis (group G and C streptococcus) is higher than that due to Streptococcus pyogenes among Mumbai school children" 59 : 220-223, 2010

      22 Takahashi T, "Clinical aspects of invasive infections with Streptococcus dysgalactiae ssp. equisimilis in Japan: differences with respect to Streptococcus pyogenes and Streptococcus agalactiae infections" 16 : 1097-1103, 2010

      23 Mejia LM, "Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein" 35 : 3220-3224, 1997

      24 Sylvetsky N, "Bacteremia due to beta-hemolytic Streptococcus group G: increasing incidence and clinical characteristics of patients" 112 : 622-626, 2002

      25 Liao CH, "Bacteremia caused by group G streptococci, Taiwan" 14 : 837-840, 2008

      26 Bert F, "Analysis of genetic relationships among strains of groups A, C and G streptococci by random amplified polymorphic DNA analysis" 45 : 278-284, 1996

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2012-05-21 학술지명변경 한글명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine
      외국어명 : The Korean Journal of Laboratory Medicine -> Annals of Laboratory Medicine
      KCI등재
      2011-01-01 평가 학술지 분리 (기타) KCI등재
      2010-06-29 학술지명변경 한글명 : 대한진단검사의학회지 -> The Korean Journal of Laboratory Medicine KCI등재
      2009-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2007-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2002-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1999-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.51 0.18 1.15
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.91 0.81 0.458 0.08
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼